Literature DB >> 15178433

Binding site analysis of full-length alpha1a adrenergic receptor using homology modeling and molecular docking.

Alessandro Pedretti1, Maria Elena Silva, Luigi Villa, Giulio Vistoli.   

Abstract

The recent availability of crystal structure of bovine rhodopsin offers new opportunities in order to approach the construction of G protein coupled receptors. This study focuses the attention on the modeling of full-length alpha(1a) adrenergic receptor (alpha(1a)-AR) due to its biological role and significant implications in pharmacological treatment of benign prostate hyperplasia. This work could be considered made up by two main steps: (a) the construction of full structure of alpha(1a)-AR, through homology modeling methods; (b) the automated docking of an endogenous agonist, norepinephrine, and of an antagonist, WB-4101, using BioDock program. The obtained results highlight the key residues involved in binding sites of both agonists and antagonists, confirming the mutagenesis data and giving new suggestions for the rational design of selective ligands.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15178433     DOI: 10.1016/j.bbrc.2004.04.149

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Modelling the interaction of catecholamines with the alpha 1A adrenoceptor towards a ligand-induced receptor structure.

Authors:  Gemma K Kinsella; Isabel Rozas; Graeme W Watson
Journal:  J Comput Aided Mol Des       Date:  2005-06       Impact factor: 3.686

2.  Computational studies of the binding site of alpha1A-adrenoceptor antagonists.

Authors:  Minyong Li; Hao Fang; Lupei Du; Lin Xia; Binghe Wang
Journal:  J Mol Model       Date:  2008-07-15       Impact factor: 1.810

3.  Crystal structures, absolute configurations and molecular docking studies of naftopidil enantiomers as α1D-adrenoceptor antagonists.

Authors:  Wei Xu; Junjun Huang; Renwang Jiang; Mu Yuan
Journal:  Acta Pharm Sin B       Date:  2017-05-16       Impact factor: 11.413

Review 4.  Immunomodulatory Action of Substituted 1,3,4-Thiadiazines on the Course of Myocardial Infarction.

Authors:  Alexey P Sarapultsev; Pavel M Vassiliev; Petr A Sarapultsev; Oleg N Chupakhin; Laura R Ianalieva; Larisa P Sidorova
Journal:  Molecules       Date:  2018-07-02       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.